• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺微小乳头状癌与甲状腺乳头状癌基因表达谱的比较分析

Comparative analysis of gene expression profiles of papillary thyroid microcarcinoma and papillary thyroid carcinoma.

作者信息

Kim Hoon Yub, Park Woong-Yang, Lee Kyu Eun, Park Won Seo, Chung Yoo Seung, Cho Su Jin, Youn Yeo-Kyu

机构信息

Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.

出版信息

J Cancer Res Ther. 2010 Oct-Dec;6(4):452-7. doi: 10.4103/0973-1482.77103.

DOI:10.4103/0973-1482.77103
PMID:21358079
Abstract

PURPOSE

Papillary thyroid carcinomas (PTCs) measuring 1.0 cm or less were separately defined as papillary thyroid microcarcinomas (PTMs) by the World Health Organization, emphasizing on their benign behavior. However, some reported that PTMs may have aggressive behavior, can cause regional, or even distant metastases. But till now, the characteristics of PTMs were only reviewed and described by the clinicopathological parameters, and no analysis of PTM by the gene level is available. We report on the gene expression profiles of PTMs by the oligonucleotide microarrays and the results of comparative analysis with those of PTCs.

MATERIALS AND METHODS

The gene expression profiles of 25 pairs of PTMs and their normal thyroid tissue counterparts, and 11 pairs of PTCs and their normal counterparts, were analyzed by Affymetrix Human Genome U133A. Data were analyzed by the SAM and the DAVID 2008 program to detect differentially expressed genes in supervised sample classification.

RESULTS

Two-hundred thirteen statistically significant up-regulated genes and -183 significant down-regulated genes of PTMs compared with their normal counterpart thyroid tissues, which were mainly cell adhesion-related genes and immune response genes, were detected. Two-hundred sixty-one up-regulated and -157 down-regulated genes of PTCs were also detected. In the comparative analyses of gene expression profiles of PTMs and PTCs, no significant difference was found.

CONCLUSION

PTM should not be considered as the simple occult indolent thyroid cancer, but as the earlier stage of disease which eventually evolves into PTC, because the gene expression profiles of PTMs were not different from those of PTCs.

摘要

目的

世界卫生组织将直径1.0厘米及以下的甲状腺乳头状癌(PTC)单独定义为甲状腺微小乳头状癌(PTM),强调其良性行为。然而,一些研究报道PTM可能具有侵袭性,可导致区域甚至远处转移。但迄今为止,PTM的特征仅通过临床病理参数进行回顾和描述,尚无基因水平的分析。我们报告了通过寡核苷酸微阵列检测的PTM基因表达谱以及与PTC的比较分析结果。

材料与方法

使用Affymetrix人类基因组U133A芯片分析25对PTM及其正常甲状腺组织对应物,以及11对PTC及其正常对应物的基因表达谱。通过SAM和DAVID 2008程序分析数据,以检测监督样本分类中差异表达的基因。

结果

与正常甲状腺组织对应物相比,检测到PTM有213个统计学上显著上调的基因和183个显著下调的基因,主要是细胞黏附相关基因和免疫反应基因。还检测到PTC有261个上调基因和157个下调基因。在PTM和PTC基因表达谱的比较分析中,未发现显著差异。

结论

PTM不应被视为简单的隐匿性惰性甲状腺癌,而应被视为最终演变为PTC的疾病早期阶段,因为PTM的基因表达谱与PTC并无差异。

相似文献

1
Comparative analysis of gene expression profiles of papillary thyroid microcarcinoma and papillary thyroid carcinoma.甲状腺微小乳头状癌与甲状腺乳头状癌基因表达谱的比较分析
J Cancer Res Ther. 2010 Oct-Dec;6(4):452-7. doi: 10.4103/0973-1482.77103.
2
Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.分化型甲状腺肿瘤的基因表达谱分析:诊断及临床意义
Clin Cancer Res. 2004 Oct 1;10(19):6586-97. doi: 10.1158/1078-0432.CCR-04-0053.
3
Immunohistochemical analysis of expression of bcl-2 protein in papillary carcinomas and papillary microcarcinomas of the thyroid gland.甲状腺乳头状癌和甲状腺微小乳头状癌中bcl-2蛋白表达的免疫组织化学分析
Exp Oncol. 2004 Dec;26(4):282-6.
4
Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.中东地区乳头状甲状腺癌的全基因组表达分析揭示c-MET是癌症治疗的新靶点。
J Pathol. 2007 Oct;213(2):190-9. doi: 10.1002/path.2215.
5
Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.通过cDNA阵列对高分化型人甲状腺癌进行分子特征分析。
Int J Oncol. 2006 Nov;29(5):1041-51.
6
c-Met expression in tall cell variant papillary carcinoma of the thyroid.c-Met在甲状腺高细胞型乳头状癌中的表达。
Cancer. 2003 Oct 1;98(7):1386-93. doi: 10.1002/cncr.11638.
7
Galectin-3 expression in papillary microcarcinoma of the thyroid.半乳糖凝集素-3在甲状腺微小乳头状癌中的表达
Histopathology. 2005 Aug;47(2):209-14. doi: 10.1111/j.1365-2559.2005.02199.x.
8
Gene expression profiles in thyroid carcinomas.甲状腺癌中的基因表达谱
Br J Cancer. 2000 Dec;83(11):1495-502. doi: 10.1054/bjoc.2000.1483.
9
Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?甲状腺微小乳头状癌:原发性肿瘤中细胞周期蛋白D1或半乳糖凝集素-3的免疫组化表达是否为转移性疾病的指标?
Acta Oncol. 2008;47(3):451-7. doi: 10.1080/02841860701630242. Epub 2007 Sep 28.
10
Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.间变性甲状腺癌中转录延伸因子A(SII)样4(TCEAL4)的下调
BMC Cancer. 2006 Nov 1;6:260. doi: 10.1186/1471-2407-6-260.

引用本文的文献

1
Papillary thyroid microcarcinoma with contralateral large humerus metastasis and cervical lymph node metastasis: A case report.甲状腺乳头状微小癌伴对侧肱骨大转移及颈部淋巴结转移:一例报告
Front Oncol. 2022 Aug 10;12:924465. doi: 10.3389/fonc.2022.924465. eCollection 2022.
2
Analysis of Curative Effect and Influencing Factors of N1 Stage Papillary Thyroid Micro-Carcinoma and Papillary Thyroid Non-Micro Carcinoma After Initial Radioactive Iodine Ablation Therapy.N1期甲状腺微小乳头状癌和甲状腺非微小乳头状癌首次放射性碘消融治疗后的疗效及影响因素分析
Cancer Manag Res. 2021 Feb 12;13:1427-1434. doi: 10.2147/CMAR.S292395. eCollection 2021.
3
Genomic and Transcriptomic Characteristics According to Size of Papillary Thyroid Microcarcinoma.
根据甲状腺微小乳头状癌大小的基因组和转录组特征
Cancers (Basel). 2020 May 25;12(5):1345. doi: 10.3390/cancers12051345.
4
Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.长链非编码 RNA SNHG22 通过与 microRNA-429 竞争结合增加 ZEB1 表达,促进甲状腺乳头状癌的恶性发展。
Cell Cycle. 2020 May;19(10):1186-1199. doi: 10.1080/15384101.2020.1749466. Epub 2020 Apr 19.
5
Comparison of the prevalence of incidental and non-incidental papillary thyroid microcarcinoma during 2008-2016: a single-center experience.2008-2016 年偶然和非偶然甲状腺微小乳头状癌发病率的比较:单中心经验。
World J Surg Oncol. 2018 Oct 10;16(1):202. doi: 10.1186/s12957-018-1501-8.
6
MicroRNA-150 suppresses the growth and malignant behavior of papillary thyroid carcinoma cells via downregulation of MUC4.微小RNA-150通过下调MUC4抑制甲状腺乳头状癌细胞的生长和恶性行为。
Exp Ther Med. 2018 Jul;16(1):45-52. doi: 10.3892/etm.2018.6197. Epub 2018 May 18.
7
The Genetics of Papillary Microcarcinomas of the Thyroid: Diagnostic and Prognostic Implications.甲状腺微小乳头状癌的遗传学:诊断及预后意义
Curr Genomics. 2017 Jun;18(3):244-254. doi: 10.2174/1389202918666170105094459.
8
Ultrasonic features of papillary thyroid microcarcinoma coexisting with a thyroid abnormality.甲状腺微小乳头状癌合并甲状腺异常的超声特征
Oncol Lett. 2016 Oct;12(4):2451-2456. doi: 10.3892/ol.2016.4999. Epub 2016 Aug 11.
9
Extensive bone metastases as the initial symptom of papillary thyroid microcarcinoma: A case report.广泛骨转移作为甲状腺微小乳头状癌的首发症状:一例报告
Exp Ther Med. 2015 Jun;9(6):2104-2108. doi: 10.3892/etm.2015.2423. Epub 2015 Apr 14.
10
Molecular pathways associated with aggressiveness of papillary thyroid cancer.与甲状腺乳头状癌侵袭性相关的分子途径。
Curr Genomics. 2014 Jun;15(3):162-70. doi: 10.2174/1389202915999140404100958.